• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用源自严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的T细胞表位开发基于肽的疫苗。

Development of a peptide-based vaccine using a T cell epitope derived from SARS-CoV-2.

作者信息

Baba Satoshi, Hayashi Hiroki, Yoshida Shota, Yin Nanxiang, Shimamura Munehisa, Morishita Ryuichi, Rakugi Hiromi, Nakagami Hironori, Yamamoto Koichi

机构信息

Department of Health Development and Medicine, Osaka University, Suita, Osaka, Japan.

Department of Geriatric Medicine, Osaka University, Suita, Osaka, Japan.

出版信息

iScience. 2025 Apr 28;28(6):112542. doi: 10.1016/j.isci.2025.112542. eCollection 2025 Jun 20.

DOI:10.1016/j.isci.2025.112542
PMID:40487437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12141072/
Abstract

Follicular helper T (Tfh) cells are a subset of CD4 T cells that help B cells to produce high-affinity antibodies. Efficient Tfh cell induction by vaccines is critical for protective efficacy against diseases. A Tfh epitope, identified from the SARS-CoV-2 spike protein, has been shown to bind to the corresponding HLA and activates Tfh cells. Here, we assessed the efficacy of a peptide vaccine conjugated with SARS-CoV-2 Tfh epitope against experimental hypertension in a mouse model. The Tfh-angiotensin II (Tfh-Ang II) vaccine activated Tfh and germinal center B cells and induced antibodies against Ang II, thereby suppressing hypertension. However, Ang II-specific autoreactive T cells were not induced. Interestingly, Tfh-Ang II-induced antibody production was enhanced by SARS-CoV-2 spike priming. Moreover, human peripheral blood mononuclear cells from individuals vaccinated with COVID-19 mRNA vaccine were activated by Tfh epitope. Collectively, the SARS-CoV-2 spike-derived universal Tfh epitope may be effective for peptide-based vaccine development.

摘要

滤泡辅助性T(Tfh)细胞是CD4 T细胞的一个亚群,可帮助B细胞产生高亲和力抗体。疫苗有效诱导Tfh细胞对于疾病的保护效果至关重要。从严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白中鉴定出的一个Tfh表位,已被证明可与相应的人类白细胞抗原(HLA)结合并激活Tfh细胞。在此,我们在小鼠模型中评估了与SARS-CoV-2 Tfh表位偶联的肽疫苗对实验性高血压的疗效。Tfh-血管紧张素II(Tfh-Ang II)疫苗激活了Tfh细胞和生发中心B细胞,并诱导产生了抗Ang II抗体,从而抑制了高血压。然而,并未诱导出Ang II特异性自身反应性T细胞。有趣的是,SARS-CoV-2刺突蛋白预激发增强了Tfh-Ang II诱导的抗体产生。此外,来自接种了2019冠状病毒病(COVID-19)信使核糖核酸(mRNA)疫苗个体的人外周血单个核细胞被Tfh表位激活。总体而言,SARS-CoV-2刺突蛋白衍生的通用Tfh表位可能对基于肽的疫苗开发有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad66/12141072/1bd3ffdfcbce/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad66/12141072/e70141d45eb0/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad66/12141072/cb002612cb46/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad66/12141072/2abbcb81c393/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad66/12141072/ec10d162aad4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad66/12141072/1bd3ffdfcbce/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad66/12141072/e70141d45eb0/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad66/12141072/cb002612cb46/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad66/12141072/2abbcb81c393/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad66/12141072/ec10d162aad4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad66/12141072/1bd3ffdfcbce/gr4.jpg

相似文献

1
Development of a peptide-based vaccine using a T cell epitope derived from SARS-CoV-2.利用源自严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的T细胞表位开发基于肽的疫苗。
iScience. 2025 Apr 28;28(6):112542. doi: 10.1016/j.isci.2025.112542. eCollection 2025 Jun 20.
2
High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells.高亲和力、中和 SARS-CoV-2 的抗体可以在没有滤泡辅助 T 细胞的情况下产生。
Sci Immunol. 2022 Feb 4;7(68):eabl5652. doi: 10.1126/sciimmunol.abl5652.
3
A single dose of COVID-19 vaccine induces a strong T cell and B cell response in healthcare professionals recovered from SARS-CoV-2 infection.一剂 COVID-19 疫苗可诱导 SARS-CoV-2 感染康复的医护人员产生强烈的 T 细胞和 B 细胞反应。
Clin Exp Med. 2023 Jun;23(2):529-537. doi: 10.1007/s10238-022-00801-8. Epub 2022 Feb 21.
4
SARS-CoV-2 spike-specific T cells exhibit unique responses in infected and vaccinated individuals.SARS-CoV-2 刺突特异性 T 细胞在感染和接种疫苗的个体中表现出独特的反应。
Signal Transduct Target Ther. 2023 Oct 6;8(1):393. doi: 10.1038/s41392-023-01650-x.
5
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans.SARS-CoV-2 mRNA 疫苗可在人体内引发强烈且持久的滤泡辅助性 T 细胞反应。
Cell. 2022 Feb 17;185(4):603-613.e15. doi: 10.1016/j.cell.2021.12.026. Epub 2021 Dec 23.
6
Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques.早期 T 滤泡辅助细胞反应和生发中心反应与免疫恒河猴的病毒血症控制相关。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01687-18. Print 2019 Feb 15.
7
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
8
Activation and induction of antigen-specific T follicular helper cells play a critical role in recombinant SARS-CoV-2 RBD vaccine-induced humoral responses.抗原特异性滤泡辅助性T细胞的激活和诱导在重组SARS-CoV-2 RBD疫苗诱导的体液免疫反应中起关键作用。
Mol Biomed. 2023 Oct 19;4(1):34. doi: 10.1186/s43556-023-00145-z.
9
A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV.第三剂(加强针)灭活 SARS-CoV-2 疫苗可在 HIV 感染者中引发免疫原性和滤泡辅助 T 细胞反应。
Front Immunol. 2023 Nov 15;14:1264160. doi: 10.3389/fimmu.2023.1264160. eCollection 2023.
10
SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques.SARS-CoV-2 诱导恒河猴生发中心 CD4 T 滤泡辅助细胞产生强烈反应。
Nat Commun. 2021 Jan 22;12(1):541. doi: 10.1038/s41467-020-20642-x.

本文引用的文献

1
Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissue.在淋巴组织中驱动1型和2型体液反应的特异性滤泡辅助性T细胞亚群。
Cell Discov. 2024 Jun 4;10(1):64. doi: 10.1038/s41421-024-00681-0.
2
Identification of mouse CD4 T cell epitopes in SARS-CoV-2 BA.1 spike and nucleocapsid for use in peptide:MHCII tetramers.鉴定 SARS-CoV-2 BA.1 刺突蛋白和核衣壳中的小鼠 CD4 T 细胞表位,用于肽:MHCII 四聚体。
Front Immunol. 2024 Mar 11;15:1329846. doi: 10.3389/fimmu.2024.1329846. eCollection 2024.
3
Single ChAdOx1 nCoV-19 dose elicits stronger immune response in previously infected individuals than in SARS-CoV2 naive persons.
单次接种 ChAdOx1 nCoV-19 疫苗在既往感染个体中引发的免疫应答强于 SARS-CoV2 未感染个体。
Immun Inflamm Dis. 2024 Jan;12(1):e1159. doi: 10.1002/iid3.1159.
4
Genetically detoxified tetanus toxin as a vaccine and conjugate carrier protein.基因解毒破伤风毒素作为疫苗和缀合载体蛋白。
Vaccine. 2022 Aug 19;40(35):5103-5113. doi: 10.1016/j.vaccine.2022.07.011. Epub 2022 Jul 22.
5
Targeting T cells in human diseases and vaccination: rationale and practice.靶向人类疾病和疫苗接种中的 T 细胞:原理与实践。
Nat Immunol. 2022 Aug;23(8):1157-1168. doi: 10.1038/s41590-022-01253-8. Epub 2022 Jul 11.
6
Previous COVID-19 Infection and Antibody Levels After Vaccination.既往 COVID-19 感染与疫苗接种后的抗体水平。
Front Public Health. 2021 Dec 1;9:778243. doi: 10.3389/fpubh.2021.778243. eCollection 2021.
7
Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients.鉴定保守的 SARS-CoV-2 刺突表位,扩大轻症 COVID-19 患者公共 cTfh 克隆型。
J Exp Med. 2021 Dec 6;218(12). doi: 10.1084/jem.20211327. Epub 2021 Oct 14.
8
Therapeutic vaccine for chronic diseases after the COVID-19 Era.新冠疫情时代过后的慢性病治疗性疫苗。
Hypertens Res. 2021 Sep;44(9):1047-1053. doi: 10.1038/s41440-021-00677-3. Epub 2021 Jun 8.
9
Cytokine-skewed Tfh cells: functional consequences for B cell help.细胞因子偏向的 Tfh 细胞:对 B 细胞辅助的功能后果。
Trends Immunol. 2021 Jun;42(6):536-550. doi: 10.1016/j.it.2021.04.006. Epub 2021 May 8.
10
SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8 T cell activation in COVID-19 patients.SARS-CoV-2 全基因组 T 细胞表位图谱分析揭示了 COVID-19 患者中的免疫优势和大量 CD8+T 细胞激活。
Sci Immunol. 2021 Apr 14;6(58). doi: 10.1126/sciimmunol.abf7550.